Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · IEX Real-Time Price · USD
19.60
+0.35 (1.82%)
At close: Jul 19, 2024, 4:30 PM
19.49
-0.11 (-0.56%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Company Description
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.
The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.
The company’s products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations.
Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Pro-Dex, Inc.
| Country | United States |
| Founded | 1978 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 146 |
| CEO | Richard Lee Van Kirk Jr. |
Contact Details
Address: 2361 Mcgaw Avenue Irvine, California 92614 United States | |
| Phone | 949-769-3231 |
| Website | pro-dex.com |
Stock Details
| Ticker Symbol | PDEX |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000788920 |
| CUSIP Number | 74265M205 |
| ISIN Number | US74265M2052 |
| Employer ID | 84-1261240 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Richard Lee Van Kirk Jr. | Chief Executive Officer, President, Chief Operating Officer and Director |
| Alisha K. Charlton | Chief Financial Officer and Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 30, 2024 | SD | Form - SD |
| May 2, 2024 | 8-K | Current Report |
| May 2, 2024 | 10-Q | Quarterly Report |
| Feb 8, 2024 | 8-K | Current Report |
| Feb 8, 2024 | 10-Q | Quarterly Report |
| Jan 4, 2024 | 8-K | Current Report |
| Jan 3, 2024 | 8-K | Current Report |
| Dec 15, 2023 | 8-K | Current Report |
| Nov 2, 2023 | 8-K | Current Report |
| Nov 2, 2023 | 10-Q | Quarterly Report |